Despite the fact that MM is falling within the tumors of plasma cells, some surveys describe subpopulations of myeloma cells with residual expression of CD19, the presence of which is associated with an unfavorable forecast, relapses, and resistance to therapy [39,183,184]. Here, CD19 is linked to Miyoshi myopathy.